Disclosed are peptides comprising a full length p53 or a partial p53 and a mitochondrial targeting signal. Also disclosed are nucleic acids that encode peptides comprising a full length p53 or a partial p53 and a mitochondrial targeting signal. Further disclosed are methods of using the peptides and nucleic acids disclosed herein. For example, the peptides and nucleic acids can be used to treat hyperproliferative disorders.
